Annual report pursuant to Section 13 and 15(d)

License and Collaboration Agreements (Tables)

v3.23.1
License and Collaboration Agreements (Tables)
12 Months Ended
Dec. 31, 2022
License and Collaboration Agreements [Abstract]  
Reconciliation of Contract Asset Associated
A reconciliation of the closing balance of the contract asset associated with the Nyxol License Agreement is as follows as of December 31, 2022 (in thousands): 
 
Contract Asset
     
Balance as of  December 31, 2021
 
$
 
Revenue recognized – license transfer
    39,519  
Execution of Nyxol License Agreement and one-time non-refundable payment
    (35,000 )
Revenue recognized – research and development services
    331  
Reclassification to accounts receivable related to costs billed under the Nyxol License Agreement
    (1,298 )
Balance as of December 31, 2022
  $ 3,552